Stocktoria
Sintx Technologies, Inc. SINT
Sintx Technologies, Inc. (SINT) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $1.0M at a -1018.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SINT | Sintx Technologies, Inc. | 2/9 | — | — | — |
| PETV | PetVivo Holdings, Inc. | 3/9 | — | — | — |
| ICU | SeaStar Medical Holding Corp | 3/9 | — | — | — |
| EMED | Electromedical Technologies, Inc | 4/9 | — | — | — |
| CODX | Co-Diagnostics, Inc. | 1/9 | -16.26 | — | — |
| EBRCZ | EBR Systems, Inc. | 2/9 | -12.31 | — | — |
| LYRA | Lyra Therapeutics, Inc. | 2/9 | — | — | — |
About Sintx Technologies, Inc.
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
FAQ
Is SINT financially healthy?
Sintx Technologies, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does SINT pay a dividend?
No, Sintx Technologies, Inc. does not currently pay a dividend.
How profitable is SINT?
In FY2025, Sintx Technologies, Inc. had a net margin of -1018.1% and a return on equity of -353.8%.
What is the analyst price target for SINT?
The average Wall-Street price target for Sintx Technologies, Inc. is $9.12, about 481.2% above the recent price, from 4 analysts.
Is SINT a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Sintx Technologies, Inc.: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.